The following is a guest article by David Lareau, CEO at Medicomp Systems

The electronic health record (EHR) industry is at a pivotal moment. Over the past two years, market consolidation has reached unprecedented levels, with fewer EHR vendors operating now than at any other time since the platforms became federally mandated.

A 2025 Health Affairs Scholar study found that just two vendors now account for approximately 71.7% of the U.S. inpatient EHR market and about 69% of the ambulatory market, a dramatic increase over the past decade. Globally, the number of active EHR vendors has contracted from more than 1,200 in 2014 to fewer than 300 in 2024.

Notably, the Health Affairs Scholar authors cautioned that such consolidation “reduces incentives for vendors to innovate and improve usability” and introduces “systemic risks when so much of the nation’s clinical data is concentrated in so few systems.” These warnings underscore what many in healthcare already sense: competition is narrowing, and with it, the industry’s capacity for creative problem-solving and design excellence.

When only a few vendors dominate both inpatient and ambulatory markets, the risk extends beyond lost market diversity. The result is an increasingly uniform technology environment where user experience, data structure, and interoperability models evolve at the pace of the largest incumbents rather than at the speed of innovation.

A Dysfunctional Competitive Landscape

In response to consolidation, many smaller EHR vendors have attempted to differentiate by adding AI features. The approach is understandable, given the pressure to appear innovative and keep pace with market trends.

Yet in practice, many of these implementations have been superficial, aimed at marketing value rather than clinical benefit. Vendors have introduced predictive text, documentation assistance, or automation tools without addressing the underlying workflow challenges that frustrate clinicians and contribute to burnout.

Repeated cycles of private-equity investment have further stunted long-term product development. Each time ownership changes, product management teams are dismantled, roadmaps reset, and institutional knowledge lost. Companies spend years rebuilding systems that never reach maturity. The result is an industry filled with AI features that sound promising but fail to meaningfully improve usability or efficiency.

Technology alone cannot solve broken workflows. Without addressing how clinicians interact with data, and how that information is captured, validated, and made actionable, AI becomes another layer of complexity rather than a path to improvement.

Fixing What Truly Matters

Sustainable innovation will come from rethinking how technology supports clinicians. EHR systems must make clinical data accurate, complete, and usable, allowing information to flow seamlessly across care settings. The next generation of systems must prioritize data quality, clinical context, and usability over automation features that increase activity yet fail to advance clinical performance.

Effective solutions will be those that can process structured, semi-structured, and unstructured data while maintaining clinical fidelity. They must normalize inconsistent information, resolve coding inaccuracies, and identify relationships among problems, tests, and treatments. By turning disparate clinical data into a trusted, actionable resource, technology can reduce medical errors, support care continuity, and improve operational efficiency.

This is not a theoretical concept. For many years, leading health systems have adopted technologies that integrate with leading EHR platforms to improve clinical usability and workflow efficiency. These approaches use intelligent data-mapping engines, extensive clinical vocabularies, and real-time context recognition to surface relevant information at the point of care. Their success demonstrates that it is possible to enhance clinician productivity and documentation accuracy within existing EHR infrastructures without requiring a wholesale system replacement.

Actual progress will come from a design that complements clinical reasoning rather than competing with it. Systems that embed intelligence into documentation and decision support can transform EHRs from passive record-keeping tools into active clinical partners.

The Case for Competitive Diversity

Healthcare depends on innovation. Innovation depends on competition. When diversity among EHR vendors shrinks, so too does the system’s capacity for creative problem-solving. Smaller and mid-sized vendors have historically served as laboratories of progress, building tools that respond quickly to clinician needs, experimenting with interoperability models, and advancing usability far beyond what the dominant platforms offer.

Consolidation into one or two major platforms risks stagnation. A handful of dominant vendors controlling the majority of healthcare data, user interfaces, and integration standards creates a monoculture that discourages experimentation. It may promote consistency, but it also suppresses creativity. Clinicians, patients, and policymakers should question whether that path best serves the nation’s health.

Reimagining Innovation

EHR vendors that wish to remain viable in a consolidated market must look inward. Regardless of consolidation, the market will likely favor those that prioritize data usability, workflow optimization, and clinical intelligence. This means addressing the persistent barriers that prevent clinicians from efficiently capturing and using high-quality data at the point of care.

Healthcare’s digital infrastructure is too important to be left to market momentum. If one platform defines how every clinician documents, views, and interprets patient data, innovation will atrophy. 

Tangible progress requires a balanced ecosystem in which multiple vendors compete on usability, intelligence, and adaptability.

Industry consolidation calls for a more thoughtful definition of innovation grounded in data integrity, clinical relevance, and design that enhances care delivery. Vendors that pursue these principles can restore balance to the health tech landscape and foster a future where technology serves clinicians and the enterprise, rather than the other way around.